Daniel S. Mytelka

Follow

Generating author description...

All published works

Action	Title	Year	Authors
+ PDF Chat	Simulating Pandemic Disease Spread and the Impact of Interventions in Complex Societal Networks	2020	Daniel S. Mytelka
+ PDF Chat	Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapies	2014	Anita Chawla Daniel S. Mytelka Stephan D. McBride Dave Nellesen Benjamin R. Elkins Daniel Ball Anupama Kalsekar Adrian Towse Louis P. Garrison

Common Coauthors

Coauthor	Papers Together
Stephan D. McBride	1
Benjamin R. Elkins	1
Daniel Ball	1
Dave Nellesen	1
Louis P. Garrison	1
Anita Chawla	1
Adrian Towse	1
Anupama Kalsekar	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Shift From Surrogate End Point to Outcome Trials: Implications for Cardiovascular Safety Assessment in Development Programs for Antidiabetic Drugs	2011	John Marcinak Prabhakar Viswanathan Vipin Arora Lawrence E. Roebel Thomas Strack Eckhard Leifke	1
+	Impact of FDA Guidance for Developing Diabetes Drugs on Trial Design: From Policy to Practice	2011	M. Angelyn Bethel Harald Sourij	1
+	Use Of Larger Versus Smaller Drug-Safety Databases Before Regulatory Approval: The Trade-Offs	2008	Shelby D. Reed Kevin J. Anstrom Damon M. Seils Robert M. Califf Kevin A. Schulman	1
+	The Cost-Effectiveness of Drug Regulation: The Example of Thorough QT/QTc Studies	2011	Jacoline C. Bouvy Marc Koopmanschap Rashmi R. Shah Huub Schellekens	1
+ PDF Chat	Effectiveness of Interventions to Reduce Contact Rates during a Simulated Influenza Pandemic	2007	Michael Haber David K. Shay Xiaohong M. Davis Rajan Patel Xiaoping Jin Eric Weintraub Evan Orenstein W. Thompson	1
+ PDF Chat	Complexity of the Basic Reproduction Number (R<sub>0</sub>)	2018	Paul L. Delamater Erica J. Street Timothy F. Leslie Y. Tony Yang Kathryn H. Jacobsen	1
+	Early Transmissibility Assessment of a Novel Coronavirus in Wuhan, China	2020	Maimuna S. Majumder Kenneth D. Mandl	1
+ PDF Chat	Early in the epidemic: impact of preprints on global discourse about COVID-19 transmissibility	2020	Maimuna S. Majumder Kenneth D. Mandl	1
+	The Geography of COVID-19 growth in the US: Counties and Metropolitan Areas	2020	William C. Wheaton Anne Kinsella Thompson	1
+ PDF Chat	Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset	2020	Hao‐Yuan Cheng Shu-Wan Jian Ding‐Ping Liu Ta-Chou Ng Wan‐Ting Huang Hsien-Ho Lin	1
+	COVID-19 herd immunity strategies: walking an elusive and dangerous tightrope	2020	Tobias Brett Pejman Rohani	1
+	Does Density Aggravate the COVID-19 Pandemic?	2020	Shima Hamidi Sadegh Sabouri Reid Ewing	1
+ PDF Chat	A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2	2020	Tom Britton Frank Ball Pieter Trapman	1
+	Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention	2020	Sarah M. Bartsch Kelly J. O’Shea Marie C. Ferguson María Elena Bottazzi Patrick T. Wedlock Ulrich Strych James A. McKinnell Sheryl S. Siegmund Sarah N. Cox Peter J. Hotez	1
+ PDF Chat	Why COVID-19 models should incorporate the network of social interactions	2020	Helena A. Herrmann Jean‐Marc Schwartz	1
+ PDF Chat	Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong	2020	Dillon C. Adam Peng Wu Jessica Y. Wong Eric H. Y. Lau Tim K. Tsang Simon Cauchemez GM Leung Benjamin J. Cowling	1
+	Scientific consensus on the COVID-19 pandemic: we need to act now	2020	Nisreen A Alwan Rochelle Burgess Simon Ashworth Rupert Beale Nahid Bhadelia Debby Bogaert Jennifer B. Dowd Isabella Eckerle Lynn R. Goldman Trisha Greenhalgh	1